Researchers report encouraging immunotherapy options for relapsed myeloma patients ...Middle East

Researchers have published results that show encouraging therapeutic options for patients with blood cancer and multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two different antigens at the same time -- they are meant to enhance the immune system's destruction of tumour cells. While new T cell-based immunotherapies, or "T-cell redirection" therapies, such as chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies have revolutionized cancer treatment, doctors still need to determine what second-line treatments (also known as salvage therapy) are effective after a patient relapses. In t

Read More Details
Finally We wish PressBee provided you with enough information of ( Researchers report encouraging immunotherapy options for relapsed myeloma patients )

Also on site :

• ED Uncovers Deceptive Pakistani National Operating Under False Indian Identity
• Rapid Brush Fire in Maui: Emergency Evacuations and Response
• Capt Amarinder Singh Calls for Change in Ludhiana West By-Election